Literature DB >> 31112462

Neurological abnormalities in 97 dogs with detectable pituitary masses.

Marika Menchetti1, Luisa De Risio2, Greta Galli1, Giunio Bruto Cherubini3, Daniele Corlazzoli4, Massimo Baroni5, Gualtiero Gandini1.   

Abstract

Background: Pituitary tumours are common neoplasms of the sellar region in small animals. However, detailed information regarding the spectrum and severity of possible neurological signs are lacking. Objective: To retrospectively describe the neurological abnormalities in a population of dogs with a detectable pituitary mass (DPM) and relate them with the size of the mass and magnetic resonance imaging (MRI) signs of brain compression (BC). Client-owned dogs were included in the study if they had MRI showing a DPM and a detailed neurological examination. The neurological signs were evaluated in relation to the pituitary height/brain ratio (P:B ratio) and the presence/absence of brain compression.
Results: Ninety-seven dogs were enrolled. Besides abnormal mentation and behaviour (77%), gait (61%) and cranial nerve abnormalities (44%), other unreported neurological signs observed included postural abnormalities (21%), pain and/or hyperesthesia (25%) and abnormal postural and proprioceptive reactions (49%). The majority of dogs with DPM had signs of BC. The presence of a high pituitary height/brain area and BC represented a risk factor for developing mental status abnormalities.
Conclusion: Neurological signs recorded in DPM-affected dogs include not only the typical forebrain signs but also gait disturbances and hyperesthesia. Neurological signs are positively associated with increased P:B ratio and MRI signs of brain compression.

Entities:  

Keywords:  Dog; canine; mass; neurology; pituitary

Mesh:

Year:  2019        PMID: 31112462      PMCID: PMC6831018          DOI: 10.1080/01652176.2019.1622819

Source DB:  PubMed          Journal:  Vet Q        ISSN: 0165-2176            Impact factor:   3.320


  23 in total

Review 1.  Progress in transsphenoidal hypophysectomy for treatment of pituitary-dependent hyperadrenocorticism in dogs and cats.

Authors:  Björn Meij; George Voorhout; Ad Rijnberk
Journal:  Mol Cell Endocrinol       Date:  2002-11-29       Impact factor: 4.102

2.  Comparison of magnetic properties of MRI contrast media solutions at different magnetic field strengths.

Authors:  Martin Rohrer; Hans Bauer; Jan Mintorovitch; Martin Requardt; Hanns-Joachim Weinmann
Journal:  Invest Radiol       Date:  2005-11       Impact factor: 6.016

3.  Biochemical assessment of Cushing's disease in patients with corticotroph macroadenomas.

Authors:  L Katznelson; J S Bogan; J R Trob; D A Schoenfeld; E T Hedley-Whyte; D W Hsu; N T Zervas; B Swearingen; M Sleeper; A Klibanski
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

4.  A retrospective study of skull base neoplasia in 42 dogs.

Authors:  Daniel R Rissi
Journal:  J Vet Diagn Invest       Date:  2015-10-13       Impact factor: 1.279

5.  Neurologic, endocrinologic, and pathologic findings associated with large pituitary tumors in dogs: eight cases (1976-1984).

Authors:  D Sarfaty; J M Carrillo; M E Peterson
Journal:  J Am Vet Med Assoc       Date:  1988-10-01       Impact factor: 1.936

Review 6.  Pituitary corticotroph macrotumors. Diagnosis and treatment.

Authors:  S L Ihle
Journal:  Vet Clin North Am Small Anim Pract       Date:  1997-03       Impact factor: 2.093

Review 7.  Canine pituitary macrotumors.

Authors:  Sarah A Moore; Dennis P O'Brien
Journal:  Compend Contin Educ Vet       Date:  2008-01

8.  Cross-sectional imaging characteristics of pituitary adenomas, invasive adenomas and adenocarcinomas in dogs: 33 cases (1988-2006).

Authors:  Rachel E Pollard; Christopher M Reilly; Megan R Uerling; Farica D Wood; Edward C Feldman
Journal:  J Vet Intern Med       Date:  2010 Jan-Feb       Impact factor: 3.333

9.  Diagnostic imaging findings and endocrine test results in dogs with pituitary-dependent hyperadrenocorticism that did or did not have neurologic abnormalities: 157 cases (1989-2005).

Authors:  Farica D Wood; Rachel E Pollard; Megan R Uerling; Edward C Feldman
Journal:  J Am Vet Med Assoc       Date:  2007-10-01       Impact factor: 1.936

10.  Pituitary macroadenomas and macroadenocarcinomas in dogs treated with mitotane for pituitary-dependent hyperadrenocorticism: 13 cases (1981-1986).

Authors:  R W Nelson; S L Ihle; E C Feldman
Journal:  J Am Vet Med Assoc       Date:  1989-06-01       Impact factor: 1.936

View more
  4 in total

1.  A 3-Dimensional Printed Patient-Specific Surgical Guide to Facilitate Transsphenoidal Hypophysectomy in Dogs.

Authors:  Leticia Escauriaza; Joe Fenn; John McCue; Darren Roper; Helene Vandenberghe; George Nye; Bill Oxley; Nicolas Granger
Journal:  Front Vet Sci       Date:  2022-06-20

2.  Suspected Pituitary Apoplexy: Clinical Presentation, Diagnostic Imaging Findings and Outcome in 19 Dogs.

Authors:  Greta Galli; Giovanna Bertolini; Giulia Dalla Serra; Marika Menchetti
Journal:  Vet Sci       Date:  2022-04-15

Review 3.  Canine Primary Intracranial Cancer: A Clinicopathologic and Comparative Review of Glioma, Meningioma, and Choroid Plexus Tumors.

Authors:  Andrew D Miller; C Ryan Miller; John H Rossmeisl
Journal:  Front Oncol       Date:  2019-11-08       Impact factor: 6.244

4.  Clinical features and their course of pituitary carcinoma with distant metastasis in a dog.

Authors:  Munekazu Nakaichi; Toshie Iseri; Hiro Horikirizono; Yusuke Sakai; Harumichi Itoh; Hiroshi Sunahara; Kazuhito Itamoto; Kenji Tani
Journal:  J Vet Med Sci       Date:  2020-10-06       Impact factor: 1.267

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.